undamentalytics Newsletter

Andrews Deborah J: insider trades

Chief financial officer, Officer, Director at 2 companies we cover. No open-market purchases and 14 sales not made under a pre-set plan, reported from August 19, 2011 to June 30, 2021.

What happened after Andrews Deborah J’s sales?

After their sales, the shares moved +23.8% against the index over 12 months on average (a negative figure means selling was the right call); 62% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

Trade by trade

Andrews Deborah J: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 0 — — — — — — Not enough years
Purchases, 6 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the trade 0 — — — — — — Not enough years
Sales, 3 months after the report 13 +13.2% +9.3% 39% 5 1.68 0.17 No reliable evidence
Sales, 12 months after the report 13 +23.8% −17.4% 62% 5 0.96 0.39 No reliable evidence
Sales, 12 months after the trade 13 +23.6% −14.2% 62% 5 1.00 0.37 No reliable evidence

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
Staar Surgical Co STAA Chief Financial Officer013August 19, 2011March 24, 2020
Lineage Cell Therapeutics, Inc. LCTX —01June 30, 2021June 30, 2021

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
June 30, 2021June 29, 2021 LCTX Sale $56,086 not yetnot yetnot yet
March 24, 2020March 23, 2020 STAA Sale $22,868 +73.1%+185.5%+211.5%
January 23, 2020January 21, 2020 STAA Sale $4,498,689 +10.4%+113.2%+93.5%
November 15, 2019November 14, 2019 STAA Sale $144,512 −4.7%+117.4%+111.6%
April 5, 2019April 4, 2019 STAA Sale $34,350 −16.7%−2.3%−3.3%
March 22, 2019March 22, 2019 STAA Sale $32,387 −29.5%−17.4%−14.1%
May 7, 2018May 3, 2018 STAA Sale $234,626 +71.5%+12.8%+14.0%
September 4, 2013September 3, 2013 STAA Sale $643,689 −2.7%−29.5%−33.3%
August 22, 2013August 20, 2013 STAA Sale $390,450 −1.0%−30.9%−26.0%
August 15, 2013August 9, 2013 STAA Sale $45,681 +10.4%−19.2%−21.5%
August 12, 2013August 8, 2013 STAA Sale $105,539 +9.3%−19.5%−23.2%
August 7, 2013August 5, 2013 STAA Sale $138,201 +5.4%−23.2%−21.5%
May 9, 2013May 9, 2013 STAA Sale $44,800 +23.8%+53.4%+44.8%
August 19, 2011August 18, 2011 STAA Sale $197,561 +22.3%−31.0%−25.5%

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Andrews Deborah J traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.